IL115384A - 2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them - Google Patents

2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them

Info

Publication number
IL115384A
IL115384A IL11538495A IL11538495A IL115384A IL 115384 A IL115384 A IL 115384A IL 11538495 A IL11538495 A IL 11538495A IL 11538495 A IL11538495 A IL 11538495A IL 115384 A IL115384 A IL 115384A
Authority
IL
Israel
Prior art keywords
pct
pyrido
pharmaceutical compositions
compositions containing
pyrazine derivatives
Prior art date
Application number
IL11538495A
Other languages
English (en)
Other versions
IL115384A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL115384A0 publication Critical patent/IL115384A0/xx
Publication of IL115384A publication Critical patent/IL115384A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11538495A 1994-09-30 1995-09-21 2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them IL115384A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31547094A 1994-09-30 1994-09-30

Publications (2)

Publication Number Publication Date
IL115384A0 IL115384A0 (en) 1995-12-31
IL115384A true IL115384A (en) 1999-10-28

Family

ID=23224581

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11538495A IL115384A (en) 1994-09-30 1995-09-21 2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them

Country Status (34)

Country Link
US (1) US5852031A (pl)
EP (1) EP0783503B1 (pl)
JP (1) JP3287574B2 (pl)
KR (1) KR100244848B1 (pl)
CN (1) CN1068327C (pl)
AT (1) ATE209648T1 (pl)
AU (1) AU681310B2 (pl)
BR (1) BR9504230A (pl)
CA (1) CA2200959C (pl)
CO (1) CO4410335A1 (pl)
CZ (1) CZ285090B6 (pl)
DE (1) DE69524241T2 (pl)
DK (1) DK0783503T3 (pl)
ES (1) ES2166830T3 (pl)
FI (1) FI113655B (pl)
HR (1) HRP950507B1 (pl)
HU (1) HUT77354A (pl)
IL (1) IL115384A (pl)
MX (1) MX9702350A (pl)
MY (1) MY113729A (pl)
NO (1) NO308995B1 (pl)
NZ (1) NZ290936A (pl)
PE (1) PE47196A1 (pl)
PL (1) PL180899B1 (pl)
PT (1) PT783503E (pl)
RU (1) RU2163239C2 (pl)
SI (1) SI9520096A (pl)
SK (1) SK284341B6 (pl)
TR (1) TR199501194A2 (pl)
TW (1) TW406081B (pl)
UA (1) UA50720C2 (pl)
WO (1) WO1996010571A1 (pl)
YU (1) YU63795A (pl)
ZA (1) ZA958223B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US6992188B1 (en) 1995-12-08 2006-01-31 Pfizer, Inc. Substituted heterocyclic derivatives
SI0874849T1 (pl) * 1995-12-21 2001-12-31 Pfizer
US6281216B1 (en) * 1998-02-09 2001-08-28 Duphar International Research B.V. 2-aminoquinoline derivatives having d4-agonistic activity
EP0953567A3 (en) 1998-04-29 2003-04-02 Pfizer Products Inc. Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
GT199900060A (es) * 1998-05-22 2000-10-14 Polimorfos de un monoclorhidrato de pirazina cristalino y sus composiciones farmacèuticas.
GB0010757D0 (en) 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds
GB0011013D0 (en) * 2000-05-09 2000-06-28 Astrazeneca Ab Chemical compounds
EP1177792A3 (en) * 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
GB0121941D0 (en) 2001-09-11 2001-10-31 Astrazeneca Ab Chemical compounds
EP1479676A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Benzimidazole-derivatives as factor xa inhibitors
SA04250304B1 (ar) * 2003-09-26 2009-03-11 سولفاي فارماسوتيكالز بي . في مشتقات هكسا - واوكتاهيدرو - بيريدو {1،2-a} بيرازين ذات نشاط مضاد لـ nk1

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
DE3564683D1 (en) * 1984-08-07 1988-10-06 Cortial 4-(arylpiperazinylethylaminoethoxy) phenol derivatives, process for their preparation and their therapeutical application
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
DE69108743T2 (de) * 1991-01-31 1995-08-17 Pfizer Recematspaltung von trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]-pyrazin.
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
EP0737683A1 (en) * 1991-02-27 1996-10-16 Pfizer Inc. N-2-(Phthalimido)ethyl trans-piperidine-2,5-dicarboxylates as intermediates in the preparation of perhydro-1H-pyrido[1,2-a]pyrazines
HUT71488A (en) * 1991-09-25 1995-11-28 Pfizer Process for the production of neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines and pharmaceuticals compositions containing the same
CA2138018C (en) * 1992-06-16 1998-01-27 Frank J. Urban Process and intermediates for bis-aza-bicyclic anxiolytic agents
ES2133416T3 (es) * 1992-10-23 1999-09-16 Merck Sharp & Dohme Ligandos de subtipos de receptores de dopamina.
CA2146018A1 (en) * 1992-10-23 1994-05-11 Paul David Leeson Dopamine receptor subtype ligands
CA2156410A1 (en) * 1993-03-01 1994-09-15 Raymond Baker Pyrrolo-pyridine derivatives
SK106395A3 (en) * 1993-03-01 1995-12-06 Merck Sharp & Dohme Treating and treatment or prevention of mental diseases
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
AU679042B2 (en) * 1993-03-05 1997-06-19 Merck Sharp & Dohme Limited Quinolone derivatives as dopamine D4 ligands
GB9416162D0 (en) * 1994-08-10 1994-09-28 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
HRP950507B1 (en) 2002-06-30
AU3189395A (en) 1996-04-26
YU63795A (sh) 1999-03-04
FI971310L (fi) 1997-03-27
RU2163239C2 (ru) 2001-02-20
FI971310A0 (fi) 1997-03-27
NO308995B1 (no) 2000-11-27
UA50720C2 (uk) 2002-11-15
NZ290936A (en) 1998-01-26
IL115384A0 (en) 1995-12-31
SK284341B6 (sk) 2005-02-04
EP0783503A1 (en) 1997-07-16
AU681310B2 (en) 1997-08-21
NO971416L (no) 1997-05-20
MY113729A (en) 2002-05-31
KR970706282A (ko) 1997-11-03
PL180899B1 (pl) 2001-04-30
ATE209648T1 (de) 2001-12-15
CA2200959A1 (en) 1996-04-11
ES2166830T3 (es) 2002-05-01
KR100244848B1 (ko) 2000-03-02
CZ285090B6 (cs) 1999-05-12
NO971416D0 (no) 1997-03-25
EP0783503B1 (en) 2001-11-28
HUT77354A (hu) 1998-03-30
PL319636A1 (en) 1997-08-18
ZA958223B (en) 1997-04-01
TW406081B (en) 2000-09-21
DE69524241D1 (de) 2002-01-10
SI9520096A (sl) 1998-04-30
DE69524241T2 (de) 2002-06-13
US5852031A (en) 1998-12-22
CN1168672A (zh) 1997-12-24
JP3287574B2 (ja) 2002-06-04
TR199501194A2 (tr) 1996-06-21
BR9504230A (pt) 1996-08-06
CZ94797A3 (cs) 1998-07-15
SK32597A3 (en) 1998-09-09
PE47196A1 (es) 1996-11-11
DK0783503T3 (da) 2002-02-11
FI113655B (fi) 2004-05-31
HRP950507A2 (en) 1997-08-31
CN1068327C (zh) 2001-07-11
JPH09511527A (ja) 1997-11-18
PT783503E (pt) 2002-03-28
WO1996010571A1 (en) 1996-04-11
CA2200959C (en) 2000-05-23
CO4410335A1 (es) 1997-01-09
MX9702350A (es) 1997-06-28

Similar Documents

Publication Publication Date Title
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
IL115384A (en) 2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
GR3019490T3 (en) Substituted piperazines as central nervous system agents
IL124966A0 (en) 1-indanyl- and 1-indanylidene-acetic derivatives
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
HUT50325A (en) Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient
GB9318691D0 (en) Therapeutic agents
IL100458A0 (en) Pharmaceutical compositions containing antagonists of the quisqualate receptor
HUT76801A (en) 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and medicaments containing them
MY130757A (en) Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
EP0233483A3 (en) Pyrroloû1,2-a¨û4,1¨benzoxazepines, process for their preparation, pharmaceutical compositions containing these compounds and therapeutical use
ZA955941B (en) Derivatives of imidazo(1,2-a)indeno(1,2-e)pyrazine-2-carboxylic acid their preparation and medicaments containing them
IL108290A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
PL311296A1 (en) Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents
IL100128A0 (en) Pharmaceutical compositions containing an imidazobenzodiazepine
IL108283A0 (en) Use of riluzole for promoting restoration following radiation
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed